TABLE 2.
Oxidation stress response with placebo (PLA), low-dosage caffeinated energy drink (Low ED) group and high-dosage caffeinated energy drink (High ED) group before and after participation in a sprint triathlon. *Significant difference at p < 0.05.
PLA | Low ED | High ED | Main effect | p vs. L | p vs. H | L vs. H | ||
---|---|---|---|---|---|---|---|---|
Mean ± SE | F | p | p-value (Cohen’s d) | |||||
SOD (U/ml) | ||||||||
Pre | 2.1 ± 0.3 | 2.1 ± 0.3 | 2.1 ± 0.3 | 0.0 | 0.96 | |||
Post | 1.8 ± 0.2 | 1.7 ± 0.3 | 1.6 ± 0.3 | 4.1 | 0.03* | p = 0.12 | p = 0.02*(0.2) | p = 0.02*(0.2) |
p-value | p = 0.01* | p = 0.01* | p = 0.00* | |||||
Catalase (nmol/min/ml) | ||||||||
Pre | 46.8 ± 3.8 | 44.8 ± 1.8 | 49.0 ± 7.3 | 0.19 | 0.83 | |||
Post | 68.6 ± 4.2 | 63.5 ± 3.9 | 63.7 ± 2.7 | 1.7 | 0.20 | |||
p-value | p = 0.00* | p = 0.00* | p = 0.03* | |||||
TBARS (μM) | ||||||||
Pre | 7.2 ± 1.6 | 10.2 ± 1.6 | 13.0 ± 3.8 | 1.5 | 0.25 | |||
Post | 13.2 ± 4 | 5.9 ± 0.6 | 6.0 ± 0.8 | 3.8 | 0.04* | p = 0.04*(0.8) | p = 0.03*(0.7) | p = 0.46 |
p-value | p = 0.07 | p = 0.02* | p = 0.03* | |||||
GSH (μg/ml) | ||||||||
Pre | 11.8 ± 1.4 | 12.1 ± 1.1 | 13.2 ± 1.7 | 0.44 | 0.65 | |||
Post | 13.4 ± 1.6 | 13.8 ± 1.9 | 13.0 ± 2.3 | 0.14 | 0.87 | |||
p-value | p = 0.19 | p = 0.13 | p = 0.45 | |||||
GSSG (μg/ml) | ||||||||
Pre | 181.3 ± 20.3 | 194.3 ± 13.4 | 184.1 ± 10.5 | 0.3 | 0.76 | |||
Post | 184.5 ± 18.7 | 183.1 ± 12.2 | 186.5 ± 13.1 | 0.0 | 0.98 | |||
p-value | p = 0.43 | p = 0.20 | p = 0.44 | |||||
GSH/GSSG(μg/ml) | ||||||||
Pre | 0.08 ± 0.02 | 0.06 ± 0.01 | 0.07 ± 0.01 | 0.7 | 0.50 | |||
Post | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.07 ± 0.01 | 0.3 | 0.76 | |||
p-value | p = 0.45 | p = 0.10 | p = 0.48 |